Multi-Center Trials and Epidemiological Studies
Saadia Qazi, DO, MPH
Fellow
Brigham and Women's Hospital, Massachusetts, United States
Saadia Qazi, DO, MPH
Fellow
Brigham and Women's Hospital, Massachusetts, United States
Philimon Gona, PhD, MPH
Associate Professor
UMASS Boston, United States
Jane J. Lee, PhD
Director of Trial Design and Development
BAIM Institute, United States
Carol Salton, BSc
Research Associate
Beth Israel Deaconess Medical Center, Massachusetts, United States
Connie Tsao, MD
Assistant Professor
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Christopher O'Donnell, MD, MPH
Global Head Cardiovascular and Metabolism Translational Medicine
Novartis Institutes for BioMedical Research, United States
Warren J. Manning, MD
Professor of Medicine and Radiology
Harvard Medical School
Boston, Massachusetts, United States
Michael Chuang, MD
Senior Author
Beth Israel Deaconess Medical Center
Newton, Massachusetts, United States
Obesity is associated with excess burden of cardiovascular disease (CVD) as well as adverse alterations in left ventricular (LV) mass (LVM) and concentricity. LVM is commonly indexed (LVMi) to account for body size, but it is unclear what is the “optimal” measure of body size for indexation. We investigated the combined effect of severity of obesity and indexation method on LVMi and concentricity, as well as myocardial contraction fraction (MCF, a novel measure of LV systolic function) as assessed by cardiovascular magnetic resonance (CMR) imaging in a community dwelling cohort free of clinical CVD.
Methods: Framingham Offspring study participants free of myocardial infarction, heart failure, or CMR wall-motion abnormality who underwent bSSFP CMR at 1.5T were included. They were stratified by sex and body mass index (BMI) category (normal weight =18.5 to 24.9; overweight =25.0 to 29.9; grade 1 obese=30-34.9; grade 2+ obese ≥35 kg/m2). LVM was measured from contiguous short-axis images, then indexed to height (HT, m), body surface area (BSA, m2), and weight (WT, kg). We calculated MCF as LV stroke volume divided by LV myocardial volume. The ratio of LVM/LVEDV (end-diastolic volume) was used as a measure of LV concentricity.
Results: Data were available from 1334 Offspring (mean 65±9 y , 62% women) The Table shows LVMi, LV concentricity (LVM/LVEDV), and MCF stratified by BMI. LVMi by WT declined with increasing BMI in both men and women. Conversely, indexation to HT demonstrated an increasing LVMi with higher BMI. However, BSA-indexation remained consistent across BMI categories in both men and women. MCF decreased with increase in BMI from normal weight to obese. Concentricity increased with increasing BMI in both sexes.
Conclusion:
The association of LVMi with BMI varies by indexation method. Among CVD-free members of a community-dwelling cohort, in both sexes, indexation to BSA yielded values of LVMi that were consistent across categories of increasing BMI, whereas LVMi by HT increased, and LVMi by WT decreased, with greater BMI. Concentricity increased with increasing categories of BMI, while MCF decreased. These adverse alterations of MCF and concentricity may provide additional insight into obesity-related LV remodeling over LVMi alone. These data lay the groundwork for future outcomes analyses, in this population and in larger prospective cohorts, regarding the predictive utility of various methods of LVM indexation.